Metraipolis › archive › dc_00fc96b3e545

Changes in patient-reported outcomes (PROs) and fecal calprotectin levels in patients with inflammatory bowel disease following a three-week gastrointestinal… — Europe PMC PMID:40880436

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40880436
DOI
10.1371/journal.pone.0330922
License (as archived)
solo-consultazione
Archived
2026-11-10T07:05:04.592Z
SHA-256 of the archived text
1b32bbbdc87c8520d3c24da10edfa79783a80b5332fc4aec0ed716b9ef59616c
Stable URL of this page
https://metraipolis.com/documento/dc_00fc96b3e545

How to cite

Changes in patient-reported outcomes (PROs) and fecal calprotectin levels in patients with inflammatory bowel disease following a three-week gastrointestinal… — Europe PMC PMID:40880436 — Europe PMC (en), https://europepmc.org/article/MED/40880436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00fc96b3e545 (Metraipolis archive dc_00fc96b3e545, sha256 1b32bbbdc87c8520d3c24da10edfa79783a80b5332fc4aec0ed716b9ef59616c)
BibTeX
@misc{dc00fc96b3e545,
  title = {Changes in patient-reported outcomes (PROs) and fecal calprotectin levels in patients with inflammatory bowel disease following a three-week gastrointestinal… — Europe PMC PMID:40880436},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40880436},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00fc96b3e545; sha256 1b32bbbdc87c8520d3c24da10edfa79783a80b5332fc4aec0ed716b9ef59616c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40880436. Agents can read the archived copy with the MCP tool read_document.